149 related articles for article (PubMed ID: 9881592)
1. Alpha-melanotropin hormone inhibits the binding of [3H]SCH 23390 to the dopamine D1 receptor in vitro.
Lezcano NE; Salvatierra NA; Celis ME
Eur J Pharmacol; 1998 Dec; 363(2-3):211-5. PubMed ID: 9881592
[TBL] [Abstract][Full Text] [Related]
2. Effect of neuropeptide-EI on the binding of [3H]SCH 23390 to the dopamine D1 receptor in rat striatal membranes.
Sanchez MS; Salvatierra NA; Vettori G; Celis ME
Neurochem Res; 2001 May; 26(5):533-7. PubMed ID: 11513481
[TBL] [Abstract][Full Text] [Related]
3. The kinetics of [3H]SCH 23390 dissociation from rat striatal dopamine D1 receptors: effect of dopamine.
Farrell CB; O'Boyle KM
Eur J Pharmacol; 1994 Jun; 268(1):79-88. PubMed ID: 7925614
[TBL] [Abstract][Full Text] [Related]
4. alpha-MSH changes cyclic AMP levels in rat brain slices by an interaction with the D1 dopamine receptor.
Lezcano NE; De Barioglio SR; Celis ME
Peptides; 1995; 16(1):133-7. PubMed ID: 7716065
[TBL] [Abstract][Full Text] [Related]
5. Binding sites for [3H]SCH 23390 in retina: properties and possible relationship to dopamine D1-receptors mediating stimulation of adenylate cyclase.
Makman MH; Dvorkin B
Brain Res; 1986 Dec; 387(3):261-70. PubMed ID: 2950967
[TBL] [Abstract][Full Text] [Related]
6. Attenuation of SCH 23390-induced alteration of striatal dopamine D1 receptor ontogeny by prolyl-leucyl-glycinamide in the rat.
Kostrzewa RM; Saleh MI
Neuropharmacology; 1989 Aug; 28(8):805-10. PubMed ID: 2571103
[TBL] [Abstract][Full Text] [Related]
7. D2 receptor antagonists do not modify guanine nucleotide-sensitive interactions between dopamine and D1 dopamine receptors under in vitro conditions.
Farrell CB; Lawlor M; Dunne A; O'Boyle KM
J Neurochem; 1995 Sep; 65(3):1124-30. PubMed ID: 7643090
[TBL] [Abstract][Full Text] [Related]
8. Interaction between alpha-MSH and gabaergic agents upon striatal cAMP levels: an in vitro model.
Cremer MC; De Barioglio SR; Celis ME
Peptides; 1998; 19(2):383-8. PubMed ID: 9493872
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity studies of alpha-melanotropin fragments on cAMP production in striatal slices.
Cecilia Cremer M; Silvina Sanchez M; Ester Celis M
Peptides; 2000 Jun; 21(6):803-6. PubMed ID: 10959000
[TBL] [Abstract][Full Text] [Related]
10. Effect of desipramine during infancy and preweanling on dorsal striatal dopamine D1 and D2 receptor binding in adolescence in the rat.
Hilakivi I; Rinne J; Marjamäki P
Pol J Pharmacol; 1999; 51(4):311-6. PubMed ID: 10540962
[TBL] [Abstract][Full Text] [Related]
11. (+/-)-3-[4'-(N,N-dimethylamino)cinnamyl]benzazepine analogs: novel dopamine D1 receptor antagonists.
Shah JH; Kline RH; Geter-Douglass B; Izenwasser S; Witkin JM; Newman AH
J Med Chem; 1996 Aug; 39(17):3423-8. PubMed ID: 8765528
[TBL] [Abstract][Full Text] [Related]
12. Similar pharmacological properties of 8-OH-DPAT and alnespirone (S 20499) at dopamine receptors: comparison with buspirone.
Protais P; Lesourd M; Comoy E
Eur J Pharmacol; 1998 Jul; 352(2-3):179-87. PubMed ID: 9716353
[TBL] [Abstract][Full Text] [Related]
13. Striatal dopamine D1-like receptors have higher affinity for dopamine in ethanol-treated rats.
May T
Eur J Pharmacol; 1992 May; 215(2-3):313-6. PubMed ID: 1396997
[TBL] [Abstract][Full Text] [Related]
14. Age-related changes of dopamine D1-like and D2-like receptor binding in the F344/N rat striatum revealed by positron emission tomography and in vitro receptor autoradiography.
Suzuki M; Hatano K; Sakiyama Y; Kawasumi Y; Kato T; Ito K
Synapse; 2001 Sep; 41(4):285-93. PubMed ID: 11494399
[TBL] [Abstract][Full Text] [Related]
15. Evidence for different states of the dopamine D1 receptor: clozapine and fluperlapine may preferentially label an adenylate cyclase-coupled state of the D1 receptor.
Andersen PH; Braestrup C
J Neurochem; 1986 Dec; 47(6):1822-31. PubMed ID: 2945903
[TBL] [Abstract][Full Text] [Related]
16. [3H]SCH 39166, a new D1-selective radioligand: in vitro and in vivo binding analyses.
McQuade RD; Duffy RA; Anderson CC; Crosby G; Coffin VL; Chipkin RE; Barnett A
J Neurochem; 1991 Dec; 57(6):2001-10. PubMed ID: 1834801
[TBL] [Abstract][Full Text] [Related]
17. Chronic antagonist treatment does not alter the mode of interaction of dopamine with rat striatal dopamine receptors.
O'Boyle KM; Gavin KT; Harrison N
J Recept Res; 1993; 13(1-4):329-39. PubMed ID: 8450496
[TBL] [Abstract][Full Text] [Related]
18. Effect of SCH 39166, a novel dopamine D1 receptor antagonist, on [3H]acetylcholine release in rat striatal slices.
Tedford CE; Crosby G; Iorio LC; Chipkin RE
Eur J Pharmacol; 1992 Feb; 211(2):169-76. PubMed ID: 1535318
[TBL] [Abstract][Full Text] [Related]
19. Effects of various isoquinoline alkaloids on in vitro 3H-dopamine uptake by rat striatal synaptosomes.
Protais P; Arbaoui J; Bakkali EH; Bermejo A; Cortes D
J Nat Prod; 1995 Oct; 58(10):1475-84. PubMed ID: 8676127
[TBL] [Abstract][Full Text] [Related]
20. GTP regulation of (-)-stepholidine binding to R(H) of D1 dopamine receptors in calf striatum.
Dong ZJ; Chen LJ; Jin GZ; Creese I
Biochem Pharmacol; 1997 Jul; 54(2):227-32. PubMed ID: 9271326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
